Literature DB >> 3191942

Influence of exercise on plasma concentrations of isosorbide dinitrate.

M G Bogaert1, R A Lefebvre, M T Rosseel, J Bouckaert.   

Abstract

As the fall in hepatic blood flow caused by exercise is expected to decrease the elimination of high extraction drugs, the influence of exercise on the fate of the anti-anginal drug isosorbide dinitrate has been assessed. Isosorbide dinitrate 10 mg was given orally, after an overnight fast, on 2 different days to 7 healthy volunteers and the plasma concentrations of the parent compound and its mononitrate metabolites were measured. Heavy bicycle exercise from the 45th to the 105th min after intake of the drug on one of the experimental days did not change the plasma isosorbide dinitrate concentrations as compared to those on the rest day. The concentrations of both mononitrates were lower on the exercise day, but the difference was already present before the exercise started.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191942     DOI: 10.1007/bf00609256

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature.

Authors:  T F Barkve; K Langseth-Manrique; J E Bredesen; K Gjesdal
Journal:  Am Heart J       Date:  1986-09       Impact factor: 4.749

2.  Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans.

Authors:  J Mooy; B Arends; J van Kemenade; R Boehm; K H Rahn; M van Baak
Journal:  J Cardiovasc Pharmacol       Date:  1986 Sep-Oct       Impact factor: 3.105

3.  The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine.

Authors:  S Weber; D de Lauture; E Rey; T Darragon; J P Severins; A Ditisheim; G Olive; M Degeorges
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

4.  Prolonged plasma half-life after oral isosorbide dinitrate in patients with angina pectoris.

Authors:  H L Fung; J O Parker
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

5.  Drugs--some basic concepts.

Authors:  G D Sweeney
Journal:  Med Sci Sports Exerc       Date:  1981       Impact factor: 5.411

Review 6.  Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 7.  Effect of acute and chronic exercise on hepatic drug metabolism.

Authors:  M Døssing
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

8.  Influence of physical exercise on the pharmacokinetics of propranolol.

Authors:  B G Arends; R O Böhm; J E van Kemenade; K H Rahn; M A van Baak
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Hepatic extraction of isosorbide dinitrate in cardiac patients.

Authors:  R A Morrison; U W Wiegand; E Jähnchen; D Höhmann; W Kasper; T Meinertz; H L Fung
Journal:  Clin Pharmacol Ther       Date:  1983-12       Impact factor: 6.875

10.  Influence of beta-blocker coadministration on the kinetics of isosorbide mononitrate and dinitrate.

Authors:  H R Ochs; G Neugebauer; D J Greenblatt; L Labedzki
Journal:  Klin Wochenschr       Date:  1986-12-01
View more
  1 in total

Review 1.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.